chloramphenicol has been researched along with probenecid in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (48.39) | 18.7374 |
1990's | 1 (3.23) | 18.2507 |
2000's | 8 (25.81) | 29.6817 |
2010's | 6 (19.35) | 24.3611 |
2020's | 1 (3.23) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Topliss, JG; Yoshida, F | 1 |
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Christensen, LK; Hansen, JM | 1 |
Thatcher, RW | 1 |
Berger, W | 1 |
Odar-Cederlöf, I; Säwe, J; von Bahr, C; Yue, Q | 1 |
Willcox, RR | 1 |
Fabre, J; Herrera, A; Perrin, L; Petitpierre, B; Rudhardt, M | 1 |
Broughton, W; Goldman, JN | 1 |
Fabre, J; Perrin, L; Petitpierre, B; Rudhardt, M | 1 |
Sim, SK | 1 |
Graber, CD; Jervey, LP; Ostrander, WE; Salley, LH; Weaver, RE | 1 |
Beaty, HN; Petersdorf, RG; Turck, M | 1 |
Hedström, SA | 1 |
Germer, S; Shann, F | 2 |
SILBERSTEIN, EB | 1 |
BEATTY, JO; BOGER, WP; MATTEUCCI, WV | 1 |
5 review(s) available for chloramphenicol and probenecid
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug interactions with oral sulphonylurea hypoglycaemic drugs.
Topics: Allopurinol; Analgesics; Anticoagulants; Chloramphenicol; Chlorpropamide; Disulfiram; Drug Interactions; Ethanol; Glyburide; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Kinetics; Monoamine Oxidase Inhibitors; Novobiocin; Phenylbutazone; Phenytoin; Probenecid; Propranolol; Rifampin; Sulfonamides; Sulfonylurea Compounds; Tolbutamide | 1977 |
A survey of problems in the antibiotic treatment of gonorrhoea. With special reference to South-East Asia.
Topics: Anti-Bacterial Agents; Asia, Southeastern; Chloramphenicol; Erythromycin; Female; Gonorrhea; Humans; Injections; Male; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins; Probenecid; Spectinomycin; Sulfathiazoles; Sulfonamides; Tetracycline | 1970 |
26 other study(ies) available for chloramphenicol and probenecid
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Treatment of acute gonococcal conjunctivitis.
Topics: Adolescent; Adult; Chloramphenicol; Conjunctivitis; Corneal Ulcer; Drug Administration Schedule; Drug Therapy, Combination; Female; Gonorrhea; Humans; Infant, Newborn; Male; Ophthalmia Neonatorum; Penicillin G Procaine; Probenecid; Tetracyclines | 1978 |
[Interactions between oral antidiabetics and other drugs].
Topics: Chloramphenicol; Coumarins; Drug Interactions; Humans; Hypoglycemic Agents; Probenecid; Sulfonamides | 1976 |
Glucuronidation of codeine and morphine in human liver and kidney microsomes: effect of inhibitors.
Topics: Adult; Amitriptyline; Chloramphenicol; Codeine; Diazepam; Glucuronates; Glucuronosyltransferase; Humans; In Vitro Techniques; Kidney; Kinetics; Microsomes; Microsomes, Liver; Morphine; Oxazepam; Probenecid | 1990 |
Behaviour of chlorpropamide in renal insufficiency and under the effect of associated drug therapy.
Topics: Acenocoumarol; Allopurinol; Chloramphenicol; Chlorpropamide; Clofibrate; Glomerular Filtration Rate; Glomerulonephritis; Half-Life; Humans; Kidney; Kidney Diseases; Probenecid; Pyelonephritis | 1972 |
The intraocular penetration of chloramphenicol succinate in rabbits.
Topics: Ampicillin; Animals; Aqueous Humor; Biological Assay; Chloramphenicol; Conjunctiva; Eye; Injections; Injections, Intramuscular; Injections, Intraperitoneal; Probenecid; Rabbits; Streptococcus; Time Factors | 1973 |
[Behavior of chlorpropamide in nephropathies in the presence of associated drugs].
Topics: Allopurinol; Chloramphenicol; Chlorpropamide; Chromium Isotopes; Humans; Kidney Diseases; Probenecid | 1972 |
Chemotherapy of gonorrhea: a review of current status.
Topics: Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Erythromycin; Gonorrhea; Humans; Kanamycin; Penicillins; Probenecid; Rifampin; Sulfonamides; Trimethoprim | 1972 |
Endocarditis due to a lanthanic, unclassified Gram-negative bacterium (group IV d).
Topics: Adult; Ampicillin; Bacteria; Chloramphenicol; Endocarditis, Bacterial; Humans; Male; Penicillin G; Penicillin Resistance; Probenecid; Sepsis | 1968 |
Activity of broad-spectrum antibiotics against enterococci and their efficacy in enterococcal endocarditis.
Topics: Administration, Oral; Ampicillin; Cephaloridine; Cephalothin; Chloramphenicol; Endocarditis, Bacterial; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Microbial Sensitivity Tests; Penicillin G; Probenecid; Streptococcus; Streptomycin; Tetracycline; Time Factors | 1967 |
General and local antibiotic treatment of chronic osteomyelitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Blood Sedimentation; C-Reactive Protein; Child; Chloramphenicol; Chronic Disease; Cloxacillin; Colistin; Female; Fistula; Humans; Injections; Male; Middle Aged; Osteomyelitis; Probenecid; Prognosis; Recurrence; Staphylococcal Infections; Staphylococcus | 1969 |
Treatment of bacterial meningitis without intravenous fluids.
Topics: Chloramphenicol; Drug Therapy, Combination; Humans; Meningitis, Haemophilus; Penicillins; Probenecid | 1983 |
Treatment of bacterial meningitis in children without intravenous fluids.
Topics: Administration, Oral; Anti-Bacterial Agents; Chloramphenicol; Humans; Infant; Injections, Intramuscular; Meningitis; Penicillin G; Probenecid; Prospective Studies | 1981 |
ERYSIPELOTHRIX ENDOCARDITIS: REPORT OF A CASE WITH CEREBRAL MANIFESTATIONS.
Topics: Brain Diseases; Chloramphenicol; Chlorothiazide; Digoxin; Diuretics; Drug Therapy; Endocarditis; Endocarditis, Bacterial; Erysipelothrix; Heart Failure; Heart Valve Diseases; Humans; Methicillin; Organomercury Compounds; Penicillin V; Penicillins; Probenecid; Sepsis | 1965 |
'Benemid' p-(di-n-propylsulfamyl)-benzoic acid; lack of effect of aureomycin, chloromycetin, streptomycin and terramycin.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Benzoic Acid; Chloramphenicol; Chlortetracycline; Dermatologic Agents; Oxytetracycline; Probenecid; Streptomycin | 1951 |